Small caps to watch: Price targets going up on surging fintech stock ahead of earnings

  • 📰 globeandmail
  • ⏱ Reading Time:
  • 60 sec. here
  • 49 min. at publisher
  • 📊 Quality Score:
  • News: 191%
  • Publisher: 92%

Canadian News ข่าว

Canada News,Breaking News Video,Canadian Breaking News

Plus other less-known Canadian stocks making news this week

A new weekly look at some of the small-cap stocks making news - or about to. Please let us know in the comments how you like this new feature and your suggestions on what you’d like to see in the future.

Shares of London, Ont.-based VersaBank, which provides business-to-business digital banking cybersecurity services and banking, are up 20 per cent over the past month and have more than doubled over the past year. The Canadian-listed shares are currently trading near their all-time high of $25.75, reached on Nov. 29. The average target price is $26.24 based on three analyst estimates surveyed by S&P Capital IQ.

Roth recently hosted VersaBank chief executive David Taylor and president Tel Matrundola for investor meetings and Mr. Irwin said in a note that management is focused on launching its receivable purchase program product in the U.S. It’s a funding solution for point-of-sale finance companies that VersaBank has offered in Canada for about 15 years. VersaBank says Canada is the largest point-of-sale financing market in the world.of Stearns Bank Holdingford N.A. Mr.

Under the agreement, Theratechnologies said it receives exclusive rights in Canada for olezarsen, which is being evaluated for familial chylomicronemia syndrome and severe hypertriglyceridemia , and for donidalorsen, which is being evaluated for the treatment of hereditary angioedema .

เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:

 /  🏆 5. in TH
 

ขอบคุณสำหรับความคิดเห็นของคุณ ความคิดเห็นของคุณจะถูกเผยแพร่หลังจากได้รับการตรวจสอบแล้ว

ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว